These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16298583)

  • 81. Management of hepatitis C after transplantation: a long way from success.
    Dove LM
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1131-3. PubMed ID: 15489571
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Symptomatic Acute Hepatitis C Infection Following a Single Episode of Unprotected Sexual Intercourse.
    Butler B; Narayan B; Potts J; Emmanuel J
    Case Rep Infect Dis; 2016; 2016():8639098. PubMed ID: 27957361
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of Hepatitis C Virus in the Liver Transplant Recipient.
    Grant L; Crippin JS
    Curr Treat Options Gastroenterol; 2003 Dec; 6(6):517-522. PubMed ID: 14585241
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Generalised Dermatitis Induced by Pegylated Interferon-alpha-2b in a Patient Infected with Genotype-1 Hepatitis C Virus : Presentation of a Case.
    Gallelli L; Ferraro M; Mauro GF; De Sarro G
    Clin Drug Investig; 2005; 25(4):281-4. PubMed ID: 17523780
    [No Abstract]   [Full Text] [Related]  

  • 85. Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon.
    Schmidt SC; Bahra M; Bayraktar S; Berg T; Schmeding M; Pratschke J; Neuhaus P; Neumann U
    Dig Dis Sci; 2010 Jul; 55(7):2063-9. PubMed ID: 19798575
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
    Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
    Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
    Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
    J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation.
    Mukherjee S; Rogge J; Weaver L; Schafer DF
    Transplant Proc; 2003 Dec; 35(8):3042-4. PubMed ID: 14697974
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis.
    Castedal M; Felldin M; Bäckman L; Olausson M; Friman S
    Transplant Proc; 2005 Oct; 37(8):3313-4. PubMed ID: 16298583
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
    Lengyel G; Tulassay Z
    Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of recurrent hepatitis C.
    Gane E
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.
    Saab S; Wang V
    J Clin Gastroenterol; 2003 Aug; 37(2):155-63. PubMed ID: 12869888
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.
    Terrault NA
    Liver Transpl; 2003 Nov; 9(11):S95-S100. PubMed ID: 14586903
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.